Business Description
Compare
Compare
Traded in other countries / regions
IPO Date
2015-06-04Description
Sirtex Medical is an Australian oncology-focused medical device company with a novel embolic radiation therapy device, which is currently used as salvage therapy in the treatment of inoperable liver cancer. Sirtex's key product is SIR-Spheres microspheres, which utilise extremely small resin beads containing radioactive yttrium-90. SIR-Spheres are designed, manufactured, and distributed by Sirtex for approved markets in Asia-Pacific; Europe, Middle East, and Africa, or EMEA; and North America.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.71 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 20.27 | |||||
| Beneish M-Score | -4.45 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.2 | |||||
| 3-Year EBITDA Growth Rate | -42.8 | |||||
| 3-Year EPS without NRI Growth Rate | 1.6 | |||||
| 3-Year FCF Growth Rate | 24.5 | |||||
| 3-Year Book Growth Rate | 3.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.91 | |||||
| Quick Ratio | 2.87 | |||||
| Days Inventory | 23.17 | |||||
| Days Sales Outstanding | 60.77 | |||||
| Days Payable | 125.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 28.9 | |||||
| 3-Year Average Share Buyback Ratio | 0.5 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 82.82 | |||||
| Operating Margin % | -10.39 | |||||
| Net Margin % | 18.96 | |||||
| ROE % | 28.29 | |||||
| ROA % | 21.28 | |||||
| ROIC % | -48.2 | |||||
| ROC (Joel Greenblatt) % | -156.02 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 45.96 | |||||
| Forward PE Ratio | 30.12 | |||||
| PE Ratio without NRI | 45.96 | |||||
| Shiller PE Ratio | 83.84 | |||||
| Price-to-Owner-Earnings | 67.1 | |||||
| PS Ratio | 8.71 | |||||
| PB Ratio | 11.76 | |||||
| Price-to-Free-Cash-Flow | 34.52 | |||||
| Price-to-Operating-Cash-Flow | 34.03 | |||||
| EV-to-EBIT | -76.71 | |||||
| EV-to-EBITDA | -90.1 | |||||
| EV-to-Revenue | 7.97 | |||||
| Earnings Yield (Greenblatt) % | -1.3 | |||||
| FCF Yield % | 3.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with GREY:SRXTY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sirtex Medical Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0.7 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0 - 0 | ||
| Shares Outstanding (Mil) | 56.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sirtex Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sirtex Medical Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sirtex Medical Ltd Frequently Asked Questions
What is Sirtex Medical Ltd(SRXTY)'s stock price today?
The current price of SRXTY is $0.00. The 52 week high of SRXTY is $0.00 and 52 week low is $0.00.
When is next earnings date of Sirtex Medical Ltd(SRXTY)?
The next earnings date of Sirtex Medical Ltd(SRXTY) is .
Does Sirtex Medical Ltd(SRXTY) pay dividends? If so, how much?
Sirtex Medical Ltd(SRXTY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers